TorHoerman Law Offers Free Evaluation of Yaz, Yasmin and Ocella Cases as Bayer Settles Yaz Lawsuits

CHICAGO, Jan. 16, 2013 /PRNewswire/ -- Bayer, the manufacturer of Yaz, Yasmin and Ocella recently announced it has spent $750 million to settle 3,490 lawsuits brought by women who have suffered blood clots from their birth control pills. Bayer noted that as of October 31, 2012, they were aware of 12,400 additional lawsuits pending in U.S. Courts. That number is expected to increase as more women become aware of their legal rights.

TorHoerman Law encourages women that experienced a blood clot after taking Yaz, Yasmin or Ocella to contact the firm immediately to talk to an experienced attorney about whether they qualify for the settlement.

Yaz, Yasmin and Ocella all contain the active ingredient, drospirenone, which has been linked to an increased risk of forming lethal blood clots. According to an FDA study, this risk is 2 to 3 times greater than other birth control pills.

Blood clot complications can be very serious. Following are a few complications that have been linked to usage of Yaz, Yasmin and Ocella:

• Deep Vein Thrombosis (DVT) – the formation of a blood clot in a deep vein, predominantly in the legs.
• Pulmonary Embolism (PE) – a blockage caused by a blood clot that travels to the lung.
• Heart Attack – Blood clots that travel to a coronary artery blocking blood flow and causing damage to the heart muscle.
• Stroke – blood clots that travel to the brain.

TorHoerman Law is a nationally recognized leader in defective drug litigation and is actively representing clients pursuing Yaz settlements.

While Bayer's announcement of the Yaz lawsuit settlement provides an indication of potential recovery, each case must be evaluated separately. The attorneys at TorHoerman Law are currently providing free and confidential evaluation of Yaz, Yasmin and Ocella cases - more information on the litigation and the settlement can be found on the TorHoerman Law website.

SOURCE TorHoerman Law